Abstract
AIM: To evaluate and compare the hepatoprotective and immunomodulatory effects of Curcuma longa (CL), Ocimum sanctum (OS), Tinospora cordifolia (TC) and Zizyphus mauritiana (ZM) on liver injury and immunosuppression induced by Isoniazid (INH), Rifampicin (RIF) and Pyrazinamide (PZA).
Keywords: Isoniazid, Rifampicin, Pyrazinamide, Hepato-toxicity, Curcuma longa, Ocimum sanctum, Tinospora cordifolia, Zizyphus mauritiana, Hepatoprotective, Immunomodulatory
TO THE EDITOR
Inflammatory bowel disease (IBD) has emerged and dramatically increased in the last century with its cause remaining largely unknown[1,2]. Extensive studies have been conducted, and many of them involved animal experiments[3,4]. To date, an animal model that exactly replicates human IBD is still lacking[3,4]. As a result, gut damage is usually induced in animals by chemicals or observed in transgenic or knockout animals that have greatly enhanced susceptibility[3,4]. Does IBD only occur in humans, but not animals? This seems not the case. For instance, IBD is also a common disease of the digestive tract in pet dogs and cats[5,6].
Why human-like IBD could not be induced in laboratory animals? It is well known that the incidence of IBD is high in places with improved hygiene[1,2]. This was demonstrated by the high incidence of IBD in the developed countries, in people with high social, economical, educational and occupational status, and in cold regions (north-south gradient)[1,2]. Even in humans, such a big difference in IBD exists between those with poor and good hygiene condition[1,2]. The difficulty to induce IBD in laboratory animals, is not surprising considering the fact that many (rodents, rabbits, dogs, and even non-human primates) have the habit of coprophagia (eating feces)[7]. Currently, we have learned the importance of commensal gut bacteria in the genesis and development of IBD[3,8]. However, it seems that IBD would not occur with either too little or too much gut bacteria. The high incidence of IBD in pet cats and dogs may probably attribute to the extra care and cleanliness they have got. To mimic human IBD, extra-measures probably should be taken to reduce bacteria exposure in laboratory animals to emulate humans with high hygiene conditions.
Footnotes
S- Editor Liu Y L- Editor Ma JY E- Editor Wang HF
References
- 1.Lakatos PL. Recent trends in the epidemiology of inflammatory bowel diseases: up or down? World J Gastroenterol. 2006;12:6102–6108. doi: 10.3748/wjg.v12.i38.6102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Kirsner JB. Historical origins of current IBD concepts. World J Gastroenterol. 2001;7:175–184. doi: 10.3748/wjg.v7.i2.175. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Jurjus AR, Khoury NN, Reimund JM. Animal models of inf. lammatory bowel disease. J Pharmacol Toxicol Methods. 2004;50:81–92. doi: 10.1016/j.vascn.2003.12.002. [DOI] [PubMed] [Google Scholar]
- 4.Sartor RB. Review article: How. relevant to human inflammatory bowel disease are current animal models of intestinal inflammation? Aliment Pharmacol Ther. 1997;11 Suppl 3:89–96; discussion 96-97. doi: 10.1111/j.1365-2036.1997.tb00813.x. [DOI] [PubMed] [Google Scholar]
- 5.Jergens AE, Moore FM, Haynes JS, Miles KG. Idiopathic inflammatory bowel disease in dogs and cats: 84 cases (1987-1990). J Am Vet Med Assoc. 1992;201:1603–1608. [PubMed] [Google Scholar]
- 6.Tams TR. Feline inflammatory bowel disease. Vet Clin North Am Small Anim Pract. 1993;23:569–586. doi: 10.1016/s0195-5616(93)50306-6. [DOI] [PubMed] [Google Scholar]
- 7.Soave O, Brand CD. Coprophagy in animals: a review. Cornell Vet. 1991;81:357–364. [PubMed] [Google Scholar]
- 8.Danese S, Fiocchi C. Etiopathogenesis of inflammatory bowel diseases. World J Gastroenterol. 2006;12:4807–4812. doi: 10.3748/wjg.v12.i30.4807. [DOI] [PMC free article] [PubMed] [Google Scholar]